Keytruda and Opdivo: a decade review
PD-1 inhibitors have become a paramount achievement in the oncology space and have revolutionised cancer treatment over the last decade.…
Pricing and Market Access
US negotiations for first round of drugs reveal $6bn in Medicare savings
Colombia’s president signs law to strengthen pharmaceutical sector
Casgevy: Launch sequence and price analysis of the first marketed CRISPR therapy
The US Biosecure Act threatens to destabilise the pharmaceutical industry
UK’s antibiotic subscription funding model – a route to market sustainability?
Ukraine: a market access review over two years of war
AIFA’s horizon scanning 2024 predictions suggest an influx of ATMPs
